Literature DB >> 10761727

Effects of artesunate, dihydroartemisinin, and an artesunate-dihydroartemisinin combination against Toxoplasma gondii.

M E Sarciron1, C Saccharin, A F Petavy, F Peyron.   

Abstract

The effect of artesunate and its metabolite dihydroartemisinin against the cerebral cysts of Toxoplasma gondii was studied. In vitro experiments were performed with the THP-1 cell line and showed an inhibition of parasite growth of approximately 70% with 0.1-0.5 microg/ml of dihydroartemisinin for 96 hr. However, with artesunate, dihydroartemisinin, or a combination (50:50) of them, the number of tachyzoites decreased approximately 40-50% and they appeared motionless. Fifty-eight to 72 hr after washing of the tachyzoites and THP-1 cells in culture, parasitized cells reappeared. In vivo, the 50:50 artesunate-dihydroartemisinin combination produced a decrease in cerebral cysts of approximately 40% after only 5 days of treatment. However, transplantations into naive mice using brains of treated mice gave positive results.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10761727     DOI: 10.4269/ajtmh.2000.62.73

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  18 in total

Review 1.  Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity.

Authors:  Andrew J Neville; Sydney J Zach; Xiaofang Wang; Joshua J Larson; Abigail K Judge; Lisa A Davis; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

2.  Evolution of resistance in vitro reveals mechanisms of artemisinin activity in Toxoplasma gondii.

Authors:  Alex Rosenberg; Madeline R Luth; Elizabeth A Winzeler; Michael Behnke; L David Sibley
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-05       Impact factor: 11.205

Review 3.  Artemisinin and its derivatives in treating protozoan infections beyond malaria.

Authors:  Cecilia Shi Ni Loo; Nelson Siu Kei Lam; Deying Yu; Xin-Zhuan Su; Fangli Lu
Journal:  Pharmacol Res       Date:  2016-11-17       Impact factor: 7.658

4.  Artemisinin induces calcium-dependent protein secretion in the protozoan parasite Toxoplasma gondii.

Authors:  Kisaburo Nagamune; Wandy L Beatty; L David Sibley
Journal:  Eukaryot Cell       Date:  2007-08-31

5.  Is there a reduced sensitivity of dihydroartemisinin against praziquantel-resistant Schistosoma japonicum?

Authors:  Wei Wang; Hong-Jun Li; Guo-Li Qu; Yun-Tian Xing; Zhen-Kun Yang; Jian-Rong Dai; You-Sheng Liang
Journal:  Parasitol Res       Date:  2013-10-22       Impact factor: 2.289

6.  Dihydroartemisinin: a new story of an old drug against Schistosoma mansoni infection.

Authors:  Hong-Jun Li; Fu-Liang Xu; Yun-Hai Wang; Zheng-Jun Yi; Wei Wang
Journal:  Parasitol Res       Date:  2013-10-22       Impact factor: 2.289

7.  Artemisinin-resistant mutants of Toxoplasma gondii have altered calcium homeostasis.

Authors:  Kisaburo Nagamune; Silvia N J Moreno; L David Sibley
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

8.  Curcumin-arteether combination therapy of Plasmodium berghei-infected mice prevents recrudescence through immunomodulation.

Authors:  Palakkod G Vathsala; Chaitanya Dende; Viswanathan Arun Nagaraj; Debapriya Bhattacharya; Gobardhan Das; Pundi N Rangarajan; Govindarajan Padmanaban
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

9.  Formulation of Neem oil-loaded solid lipid nanoparticles and evaluation of its anti-Toxoplasma activity.

Authors:  Sara Nemati; Hanieh Mohammad Rahimi; Zahra Hesari; Meysam Sharifdini; Nooshin Jalilzadeh Aghdam; Hamed Mirjalali; Mohammad Reza Zali
Journal:  BMC Complement Med Ther       Date:  2022-05-04

10.  Artesunate Exerts a Direct Effect on Endothelial Cell Activation and NF-κB Translocation in a Mechanism Independent of Plasmodium Killing.

Authors:  Mariana C Souza; Flávio Henrique Marcolino Paixão; Fausto K Ferraris; Isabela Ribeiro; Maria das Graças M O Henriques
Journal:  Malar Res Treat       Date:  2012-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.